A study published in the British Journal of Pharmacology on 3 March, led by University of Queensland researchers Associate Professor Trent Woodruff and Dr John Lee, has found the drug “PMX205” extends the life of mice that have a SOD1 mutation, when administered before or during very early disease onset. More studies are now underway to determine the safety of PMX205 before it can be tested in humans. 'Pharmacological inhibition of complement C5a-C5a1 receptor signalling ameliorates disease pathology in the hSOD1G93A mouse model of amyotrophic lateral sclerosis' tttp://onlinelibrary.wiley.com/doi/10.1111/bph.13730/full
Postive results for PMX205 in mice with SOD1 mutation
Latest News
Christmas Appeal 2025 - How Your Donation Will Help
In the past two years, requests to our FlexEquip equipment service have grown by a whopping 64%. And in the past financial year alone, FlexEquip...
Dale's Day 2025
Dale's Day was held on October 4, and this fantastic day of fun and cricket raised an amazing $5273.40 to support families facing MND - what a wonderf...
National Carers Week 2025
This National Carers Week, we're acknowledging the amazing carers in our community. We'd like to take a moment to appreciate you for the care, dedicat...
Carers Week 2025 - Lynette's Story
For Lynette Price, being a carer of a loved one with MND is about making the most of their moments together. She and her husband care for her 1-year-o...